/other/Awakn_Life_Sciences_Corp._1169082_BC_Ltd.-logo.png)
Awakn Life Sciences Corp. (1169082 BC Ltd.) — Investor Relations & Filings
Awakn Life Sciences Corp. is a clinical-stage biotechnology company focused on researching, developing, and commercializing novel therapeutics, including psychedelic medicine, to treat addiction and psychiatric disorders. The company integrates medication-assisted treatments into mainstream healthcare through clinical operations, research, and digital platforms. Awakn's initial therapeutic focus areas are Alcohol Use Disorder (AUD) and Post-Traumatic Stress Disorder (PTSD). It is recognized for pioneering evidence-backed ketamine-assisted therapy for AUD. Its discovery programs support expansion across psychiatry and potential entry into neurology.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Decision Document / Order for Application - English.pdf | 2025-05-29 | English | |
| News release - English.pdf | 2025-05-27 | English | |
| News release - English.pdf | 2025-04-23 | English | |
| News release - English.pdf | 2025-04-11 | English | |
| Certificate re dissemination to shareholders.pdf | 2025-03-18 | English | |
| Notice of meeting - English.pdf | 2025-03-18 | English |
Browse filings by year
7 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 47438219 | Decision Document / Order for Application - English.pdf | 2025-05-29 | English | ||
| 13795843 | News release - English.pdf | 2025-05-27 | English | ||
| 32080012 | News release - English.pdf | 2025-04-23 | English | ||
| 13785387 | News release - English.pdf | 2025-04-11 | English | ||
| 13777811 | Certificate re dissemination to shareholders.pdf | 2025-03-18 | English | ||
| 13777810 | Notice of meeting - English.pdf | 2025-03-18 | English | ||
| 13777809 | Form of proxy - English.pdf | 2025-03-18 | English | ||
| 13777808 | Form of proxy - English.pdf | 2025-03-18 | English | ||
| 13777807 | Form of proxy - English.pdf | 2025-03-18 | English | ||
| 13777806 | Form of proxy - English.pdf | 2025-03-18 | English | ||
| 13777805 | Form of proxy - English.pdf | 2025-03-18 | English | ||
| 13777804 | Form of proxy - English.pdf | 2025-03-18 | English | ||
| 13777803 | Form of proxy - English.pdf | 2025-03-18 | English | ||
| 13777802 | Other.pdf | 2025-03-18 | English | ||
| 13777801 | Management information circular - English.pdf | 2025-03-18 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Awakn Life Sciences Corp. (1169082 BC Ltd.) via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/47755/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=47755 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=47755 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=47755 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 47755}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Awakn Life Sciences Corp. (1169082 BC Ltd.) (id: 47755)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.